Intervention Review

Psychostimulants for depression

  1. Bridget Candy1,*,
  2. Louise Jones2,
  3. Rachael Williams2,
  4. Adrian Tookman2,
  5. Michael King2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 23 APR 2008

Assessed as up-to-date: 10 FEB 2008

DOI: 10.1002/14651858.CD006722.pub2

How to Cite

Candy B, Jones L, Williams R, Tookman A, King M. Psychostimulants for depression. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006722. DOI: 10.1002/14651858.CD006722.pub2.

Author Information

  1. 1

    Royal Free & University College Medical School , Marie Curie Palliative Care Research Unit, Department of Mental Health Sciences, London, UK

  2. 2

    Royal Free & University College Medical School, Marie Curie Palliative Care Research Unit, Department of Mental Health Sciences, London, UK

*Bridget Candy, Marie Curie Palliative Care Research Unit, Department of Mental Health Sciences, Royal Free & University College Medical School , Hampstead Campus , Rowland Hill Street , London, NW3 2PF , UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008


Cited in:


This article has been cited by:

  1. 1
    Irvin Epstein, Isaac Szpindel, Martin A. Katzman, Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies, Psychiatry Research, 2014, 220, S15


  2. 2
    Diane Warden, Paula D. Riggs, Sung-Joon Min, Susan K. Mikulich-Gilbertson, Leanne Tamm, Kathlene Trello-Rishel, Theresa Winhusen, Major depression and treatment response in adolescents with ADHD and substance use disorder, Drug and Alcohol Dependence, 2012, 120, 1-3, 214


  3. 3
    Stania A. Dejesus, Vanessa A. Diaz, Wanda C. Gonsalves, Peter J. Carek, Identification and Treatment of Depression in Minority Populations, The International Journal of Psychiatry in Medicine, 2011, 42, 1, 69


  4. 4
    Michael T. Treadway, David H. Zald, Reconsidering anhedonia in depression: Lessons from translational neuroscience, Neuroscience & Biobehavioral Reviews, 2011, 35, 3, 537


  5. 5
    Alexander C. Tsai, Unclear clinical significance of findings on the use of referenced-EEG-guided pharmacotherapy, Journal of Psychiatric Research, 2011, 45, 1, 133


  6. 6
    Greg Irving, Mari Lloyd-Williams, Depression in advanced cancer, European Journal of Oncology Nursing, 2010, 14, 5, 395


  7. 7
    Paul Howard, John Shuster, Robert Twycross, Mary Mihalyo, Andrew Wilcock, Psychostimulants, Journal of Pain and Symptom Management, 2010, 40, 5, 789


  8. 8
    Susan E. Hardy, Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults, The American Journal of Geriatric Pharmacotherapy, 2009, 7, 1, 34


  9. 9
    Matthew Hotopf, Annabel Price, Palliative care psychiatry, Psychiatry, 2009, 8, 6, 212


  10. 10
    Bradley Ng, Psychostimulants and treatment resistant depression, Acta Psychiatrica Scandinavica, 2009, 120, 6
  11. 11
    Vincent Castagné, Roger D. Porsolt, Paul Moser, Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse, European Journal of Pharmacology, 2009, 616, 1-3, 128


  12. 12
    Klaus Linde, Michael M Berner, Levente Kriston, St John's wort for major depression, The Cochrane Library,